NFE2L2 and autoimmune polyendocrinopathy: Keeping in mind that an unbalanced accumulation of ROS has been linked to the occurrence and development of many acute and chronic diseases, including APS, pharmacological regulation of NRF2 pathways is an emerging treatment strategy.